These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 21353335)
1. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene. Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335 [TBL] [Abstract][Full Text] [Related]
2. Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma. Zuo C; Zhang H; Spencer HJ; Vural E; Suen JY; Schichman SA; Smoller BR; Kokoska MS; Fan CY Otolaryngol Head Neck Surg; 2009 Oct; 141(4):484-90. PubMed ID: 19786217 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447 [TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation: an important epigenetic mechanism for hMLH1 gene inactivation in head and neck squamous cell carcinoma. Liu K; Huang H; Mukunyadzi P; Suen JY; Hanna E; Fan CY Otolaryngol Head Neck Surg; 2002 May; 126(5):548-53. PubMed ID: 12075230 [TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation and inactivation of hMLH1, a DNA mismatch repair gene, in head and neck squamous cell carcinoma. Liu K; Zuo C; Luo QK; Suen JY; Hanna E; Fan CY Diagn Mol Pathol; 2003 Mar; 12(1):50-6. PubMed ID: 12605036 [TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Czerninski R; Krichevsky S; Ashhab Y; Gazit D; Patel V; Ben-Yehuda D Oral Dis; 2009 Apr; 15(3):206-13. PubMed ID: 19207881 [TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Puri SK; Si L; Fan CY; Hanna E Am J Otolaryngol; 2005; 26(1):12-7. PubMed ID: 15635575 [TBL] [Abstract][Full Text] [Related]
8. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells. Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327 [TBL] [Abstract][Full Text] [Related]
9. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma. Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791 [TBL] [Abstract][Full Text] [Related]
10. [Methylation of p16 and hMLH1 genes in esophageal squamous cell carcinoma and reflux esophagitis]. Wang F; Xie XJ; Piao YS; Liu B; Wang LD Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):537-41. PubMed ID: 22169643 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of DNA repair genes MLH1 and MSH2 in adenocarcinomas and squamous cell carcinomas of the lung. Gomes A; Reis-Silva M; Alarcão A; Couceiro P; Sousa V; Carvalho L Rev Port Pneumol; 2014; 20(1):20-30. PubMed ID: 24360395 [TBL] [Abstract][Full Text] [Related]
12. Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance. Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Zabarovsky ER; Roy A; Roychoudhury S; Panda CK Cancer Sci; 2010 Jun; 101(6):1511-20. PubMed ID: 20412120 [TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299 [TBL] [Abstract][Full Text] [Related]
14. hMLH1 promoter methylation is an early event in oral cancer. González-Ramírez I; Ramírez-Amador V; Irigoyen-Camacho ME; Sánchez-Pérez Y; Anaya-Saavedra G; Granados-García M; García-Vázquez F; García-Cuellar CM Oral Oncol; 2011 Jan; 47(1):22-6. PubMed ID: 21075045 [TBL] [Abstract][Full Text] [Related]
15. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer. Fox EJ; Leahy DT; Geraghty R; Mulcahy HE; Fennelly D; Hyland JM; O'Donoghue DP; Sheahan K J Mol Diagn; 2006 Feb; 8(1):68-75. PubMed ID: 16436636 [TBL] [Abstract][Full Text] [Related]
16. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer. Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668 [TBL] [Abstract][Full Text] [Related]
17. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754 [TBL] [Abstract][Full Text] [Related]
18. Implication of Reprimo and hMLH1 gene methylation in early diagnosis of gastric carcinoma. Liu L; Yang X Int J Clin Exp Pathol; 2015; 8(11):14977-82. PubMed ID: 26823831 [TBL] [Abstract][Full Text] [Related]
19. [Methylation of hMLH1 gene promoter in gastric carcinoma with microsatellite instability]. Li JH; Shi XZ; Liu M; Wang Y; Yu ZH; Xu GW; Lu S Ai Zheng; 2005 Mar; 24(3):273-7. PubMed ID: 15757526 [TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Fleisher AS; Esteller M; Tamura G; Rashid A; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Nishizuka S; James SP; Wilson KT; Herman JG; Meltzer SJ Oncogene; 2001 Jan; 20(3):329-35. PubMed ID: 11313962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]